EXCEL Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1905 participants.

Also called NCT01205776

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,905 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01205776
Other papers using this trial's data
  • Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease The New England journal of medicine, 2019-11-07 DOI, PubMed 31562798 PubMed links an erratum for this paper. Erratum: PMID 32160683
  • Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022-01-28 DOI, PubMed 34212863, PMC9724945 Not in the PMC Open Access subset.
  • Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2019-06-01 DOI, PubMed 30596978
  • Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial European journal of heart failure, 2020-05 DOI, PubMed 32043709
  • Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization Journal of the American College of Cardiology, 2020-10-06 DOI, PubMed 33004126
  • Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score Circulation. Cardiovascular interventions, 2019-09 DOI, PubMed 31495220
  • Major Bleeding and Mortality After Revascularization of Left Main Disease Journal of the American College of Cardiology, 2024-12-10 DOI, PubMed 39632005
  • Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial JACC. Cardiovascular interventions, 2020-02-10 DOI, PubMed 31954680
  • Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2020-05-20 DOI, PubMed 31422924
  • Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial Circulation, 2026-03-24 DOI, PubMed 41664927

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01205776. Randomized; no masking; primary purpose treatment. Start 2010-09-29 (actual); primary completion 2019-05-03 (actual). Results posted on 2018-03-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EXCEL Clinical Trial
Acronym
EXCEL
Condition
Chronic Coronary Occlusion
Condition
Unprotected Left Main Coronary Artery Disease
Condition
Stent Thrombosis
Condition
Vascular Disease
Condition
Myocardial Ischemia
Condition
Coronary Artery Stenosis
Condition
Coronary Disease
Condition
Coronary Restenosis
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01205776
Content hash
4d087a6e6c0bb17ae562e94101ee1e27c4e89c1de576d791a4bfb7d40aa3eaa0